Laboratory Automation in Pharmaceutical Development
Author Information
Author(s): Nigel North, Simon Smith
Primary Institution: SmithKline Beecham Pharmaceuticals
Hypothesis
The implementation of robotics in laboratory settings can reduce the development time for new pharmaceutical products.
Conclusion
The study highlights the need for improved laboratory automation to manage the increasing workload of stability studies in pharmaceutical development.
Supporting Evidence
- Robotic methods can significantly reduce the time and cost of pharmaceutical testing.
- Automation is essential to manage the increasing number of stability studies required for new drug applications.
- Improved reliability of robotic systems has led to better acceptance among product teams.
Takeaway
This study shows that using robots in labs can help make medicines faster and easier to test, which is important for getting new drugs to people.
Methodology
The study discusses the implementation of robotic methods in pharmaceutical laboratories and the challenges faced in automating processes.
Limitations
The study does not provide specific quantitative data on the effectiveness of automation compared to manual methods.
Want to read the original?
Access the complete publication on the publisher's website